Regeneron's Pasatru Shows Zero New Bone Lesions At 84 Weeks, Cuts Flare-Ups Vs Placebo Through Week 84
To Start Phase 3 Trial In FOP Children
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.